RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells
Charlotte Pilard(University of Liège), Michaël Herfs(University of Liège)
Cited by 7
Related Papers
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
|Journal for ImmunoTherapy of Cancer|2021|169